Nitric oxide synthase isoform inhibition before whole body ischemia reperfusion in pigs: Vital or protective?

Resuscitation

Volumn 74, Issue 3, 2007, Pages 516-525

  Adams, Jose A ^a   Wu, Dongmei ^a   Bassuk, Jorge ^a   Arias, Jaqueline ^a   Lozano, Hector ^a   Kurlansky, Paul ^b   Lamas, Gervasio A ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b Florida Heart Research Institute   (United States)

Author keywords

Cardiopulmonary resuscitation; Endothelial nitric oxide synthase; Inducible nitric oxide synthase; Ischemia reperfusion; Myocardial stunning; Neuronal nitric oxide synthase echocardiography; Nitric oxide; Post resuscitation myocardial dysfunction

Indexed keywords

1 (2 TRIFLUOROMETHYLPHENYL)IMIDAZOLE; AMINOGUANIDINE; BICARBONATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SODIUM CHLORIDE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BRAIN; CIRCULATION; COMPRESSION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DEFIBRILLATION; DEVICE; DRUG INFUSION; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; HYPEREMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; NONHUMAN; PNEUMATIC TOOL; PRIORITY JOURNAL; REPERFUSION; REPERFUSION INJURY; RESUSCITATION; SURVIVAL; SWINE;

ANIMALS; CARDIOPULMONARY RESUSCITATION; DISEASE MODELS, ANIMAL; ELECTRIC COUNTERSHOCK; ENZYME INHIBITORS; IMIDAZOLES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; REPERFUSION INJURY; SWINE; VENTRICULAR FIBRILLATION;

EID: 34547484898     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2007.02.009     Document Type: Article

References (61)

1. Adrie C., Laurent I., Monchi M., Cariou A., Dhainaou J.F., and Spaulding C. Postresuscitation disease after cardiac arrest: a sepsis-like syndrome?. Curr Opin Crit Care 10 3 (2004) 208-212
2. El Menyar A.A. The resuscitation outcome: revisit the story of the stony heart. Chest 128 4 (2005) 2835-2846
3. Gazmuri R.J., Kolarova J.D., and Ayoub I.M. Inotropic options for postresuscitation myocardial dysfunction. Crit Care Med 33 3 (2005) 668-670
4. Kern K.B. Postresuscitation myocardial dysfunction. Cardiol Clin 20 1 (2002) 89-101
5. Kern K.B., Hilwig R.W., Rhee K.H., and Berg R.A. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 28 1 (1996) 232-240
6. Klouche K., Weil M.H., Sun S., et al. Evolution of the stone heart after prolonged cardiac arrest. Chest 122 3 (2002) 1006-1011
7. Nava G., Adams J.A., Bassuk J., Wu D., Kurlansky P., and Lamas G.A. Echocardiographic comparison of cardiopulmonary resuscitation (CPR) using periodic acceleration (pGz) versus chest compression. Resuscitation 66 1 (2005) 91-97
8. Niemann J.T., Garner D., and Lewis R.J. Tumor necrosis factor-alpha is associated with early postresuscitation myocardial dysfunction. Crit Care Med 32 8 (2004) 1753-1758
9. Cornelussen R.N., Vanagt W.Y., Prinzen F.W., and Snoeckx L.H. Proteins involved in salvage of the myocardium. Adv Exp Med Biol 543 (2003) 277-291
10. Dawn B., and Bolli R. Role of nitric oxide in myocardial preconditioning. Ann NY Acad Sci 962 (2002) 18-41
11. Jones S.P., and Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40 1 (2006) 16-23
12. Jugdutt B.I. Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev 7 4 (2002) 391-405
13. Jugdutt B.I. Nitric oxide and cardiovascular protection. Heart Fail Rev 8 1 (2003) 29-34
14. Miller M.J. Preconditioning for cardioprotection against ischemia reperfusion injury: the roles of nitric oxide, reactive oxygen species, heat shock proteins, reactive hyperemia and antioxidants-a mini review. Can J Cardiol 17 10 (2001) 1075-1082
15. Paxinou E., Weisse M., Chen Q., et al. Dynamic regulation of metabolism and respiration by endogenously produced nitric oxide protects against oxidative stress. Proc Natl Acad Sci USA 98 20 (2001) 11575-11580
16. Casadei B. The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function. Exp Physiol 91 6 (2006) 943-955
17. Danson E.J., Choate J.K., and Paterson D.J. Cardiac nitric oxide: emerging role for nNOS in regulating physiological function. Pharmacol Ther 106 1 (2005) 57-74
18. Sears C.E., Ashley E.A., and Casadei B. Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?. Philos Trans Roy Soc Lond 359 1446 (2004) 1021-1044
19. Wiklund L., Sharma H.S., and Basu S. Circulatory arrest as a model for studies of global ischemic injury and neuroprotection. Ann NY Acad Sci 1053 (2005) 205-219
20. Hardy P., Lamireau D., Hou X., et al. Major role for neuronal NO synthase in curtailing choroidal blood flow autoregulation in newborn pig. J Appl Physiol 91 4 (2001) 1655-1662
21. Kimura H., Katsuramaki T., Isobe M., et al. Role of inducible nitric oxide synthase in pig liver transplantation. J Surg Res 111 1 (2003) 28-37
22. G-Nitro-l-arginine methyl ester: systemic and pulmonary haemodynamics, tissue blood flow and arteriovenous shunting in the pig. Naunyn-Schmiedeberg's Arch Pharmacol 348 4 (1993) 417-423
23. Adams J.A., Bassuk J., Wu D., and Kurlansky P. Cardiopulmonary resuscitation (CPR) using periodic acceleration (pGz) in an older porcine model of ventricular fibrillation. Resuscitation 60 3 (2004) 327-334
24. Adams J.A., Mangino M.J., Bassuk J., Kurlansky P., and Sackner M.A. Regional blood flow during periodic acceleration. Crit Care Med 29 10 (2001) 1983-1988
25. Casadei B., and Sears C.E. Nitric-oxide-mediated regulation of cardiac contractility and stretch responses. Prog Biophys Mol Biol 82 1-3 (2003) 67-80
26. Crisostomo P.R., Wairiuko G.M., Wang M., Tsai B.M., Morrell E.D., and Meldrum D.R. Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J Am Coll Surg 202 5 (2006) 797-812
27. Ignarro L.J. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol 53 4 Pt 1 (2002) 503-514
28. Massion P.B., Pelat M., Belge C., and Balligand J.L. Regulation of the mammalian heart function by nitric oxide. Comp Biochem Physiol A: Mol Integr Physiol 142 2 (2005) 144-150
29. Albrecht E.W., Stegeman C.A., Heeringa P., Henning R.H., and van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol 199 1 (2003) 8-17
30. Ambrosio G., and Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 138 2 Pt 2 (1999) S69-S75
31. Berges A., Van Nassauw L., Bosmans J., Timmermans J.P., and Vrints C. Role of nitric oxide and oxidative stress in ischaemic myocardial injury and preconditioning. Acta Cardiol 58 2 (2003) 119-132
32. Ferdinandy P., and Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 138 4 (2003) 532-543
33. Hoffman Jr. J.W., Gilbert T.B., Poston R.S., and Silldorff E.P. Myocardial reperfusion injury: etiology, mechanisms, and therapies. J Extra Corpor Technol 36 4 (2004) 391-411
34. Babai L., Szigeti Z., Parratt J.R., and Vegh A. Delayed cardioprotective effects of exercise in dogs are aminoguanidine sensitive: possible involvement of nitric oxide. Clin Sci (Lond) 102 4 (2002) 435-445
35. Barocelli E., Ballabeni V., Ghizzardi P., et al. The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice. Nitric Oxide 14 3 (2006) 212-218
36. Ding H.L., Zhu H.F., Dong J.W., et al. Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury. Acta Pharmacol Sin 26 3 (2005) 315-322
37. Hajnal A., Nagy O., Litvai A., Papp J., Parratt J.R., and Vegh A. Nitric oxide involvement in the delayed antiarrhythmic effect of treadmill exercise in dogs. Life Sci 77 16 (2005) 1960-1971
38. Wildhirt S.M., Weismueller S., Schulze C., Conrad N., Kornberg A., and Reichart B. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury. Cardiovasc Res 43 3 (1999) 698-711
39. Yao Y., Zhou J.Y., and Zhu X.J. The effect of inducible nitric oxide synthase inhibitor on microvascular permeability after cerebral ischemia/reperfusion. Methods Find Exp Clin Pharmacol 27 10 (2005) 701-704
40. Tang W., Weil M.H., Sun S., Pernat A., and Mason E. K(ATP) channel activation reduces the severity of postresuscitation myocardial dysfunction. Am J Physiol Heart Circ Physiol 279 4 (2000) H1609-H1615
41. Schleien C.L., Kuluz J.W., and Gelman B. Hemodynamic effects of nitric oxide synthase inhibition before and after cardiac arrest in infant piglets. Am J Physiol 274 4 Pt 2 (1998) H1378-H1385
42. Krismer A.C., Lindner K.H., Wenzel V., Rainer B., Mueller G., and Lingnau W. Inhibition of nitric oxide improves coronary perfusion pressure and return of spontaneous circulation in a porcine cardiopulmonary resuscitation model. Crit Care Med 29 3 (2001) 482-486
43. Zhang Y., Boddicker K.A., Rhee B.J., Davies L.R., and Kerber R.E. Effect of nitric oxide synthase modulation on resuscitation success in a swine ventricular fibrillation cardiac arrest model. Resuscitation 67 1 (2005) 127-134
44. Halperin H.R., Tsitlik J.E., Guerci A.D., et al. Determinants of blood flow to vital organs during cardiopulmonary resuscitation in dogs. Circulation 73 3 (1986) 539-550
45. Luce J.M., Rizk N.A., and Niskanen R.A. Regional blood flow during cardiopulmonary resuscitation in dogs. Crit Care Med 12 10 (1984) 874-878
46. Niemann J.T., Criley J.M., Rosborough J.P., Niskanen R.A., and Alferness C. Predictive indices of successful cardiac resuscitation after prolonged arrest and experimental cardiopulmonary resuscitation. Ann Emerg Med 14 6 (1985) 521-528
47. Depre C., Vanoverschelde J.L., Goudemant J.F., Mottet I., and Hue L. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 92 7 (1995) 1911-1918
48. Wu D., Bassuk J., Arias J., et al. Differential role of nitric oxide synthase isoforms in cardiopulmonary resuscitation with periodic acceleration (pGz) in pigs. Resuscitation 73 1 (2007) 144-153
49. Wu D., Bassuk J., and Arias J. Post-resuscitation reperfusion injury: comparison of periodic Gz acceleration versus Thumper CPR. Resuscitation 70 3 (2006) 454-462
50. Sears C.E., Bryant S.M., Ashley E.A., et al. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res 92 5 (2003) e52-e59
51. Conlon K., Collins T., and Kidd C. The role of nitric oxide in the control by the vagal nerves of the heart of the ferret. Exp Physiol 83 4 (1998) 469-480
52. Barouch L.A., Harrison R.W., Skaf M.W., et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416 6878 (2002) 337-339
53. Stoyanovsky D., Murphy T., Anno P.R., Kim Y.M., and Salama G. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21 1 (1997) 19-29
54. Xu L., Eu J.P., Meissner G., and Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279 5348 (1998) 234-237
55. Damy T., Ratajczak P., Robidel E., et al. Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J 17 13 (2003) 1934-1936
56. Xuan Y.T., Tang X.L., Qiu Y., et al. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol 279 5 (2000) H2360-H2371
57. Jones S.P., Girod W.G., Huang P.L., and Lefer D.J. Myocardial reperfusion injury in neuronal nitric oxide synthase deficient mice. Coron Artery Dis 11 8 (2000) 593-597
58. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., Mortara A., and Schwartz P.J. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) investigators. Lancet 351 9101 (1998) 478-484
59. Sumeray M.S., Rees D.D., and Yellon D.M. Infarct size and nitric oxide synthase in murine myocardium. J Mol Cell Cardiol 32 1 (2000) 35-42
60. Saraiva R.M., Minhas K.M., Raju S.V., et al. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium. Circulation 112 22 (2005) 3415-3422
61. Clark C.B., Zhang Y., Martin S.M., et al. The nitric oxide synthase inhibitor N(G)-nitro-l-arginine decreases defibrillation-induced free radical generation. Resuscitation 60 3 (2004) 351-357